Prothrombin Greenville, Arg517→Gln, identified in an individual heterozygous for dysprothrombinemia

被引:43
作者
Henriksen, RA [1 ]
Dunham, CK
Miller, LD
Casey, JT
Menke, JB
Knupp, CL
Usala, SJ
机构
[1] E Carolina Univ, Dept Med, Endocrinol Sect, Greenville, NC 27858 USA
[2] E Carolina Univ, Sect Hematol, Greenville, NC 27858 USA
[3] E Carolina Univ, Sect Allergy Asthma & Immunol, Greenville, NC 27858 USA
关键词
D O I
10.1182/blood.V91.6.2026.2026_2026_2031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 64-year-old white male was referred for evaluation of prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT) obtained before elective surgery with initial PT and PTT results of 14.9 and 38.4 seconds, respectively, which corrected to normal in 1:1 mixes with normal plasma, Functional prothrombin assay indicated a level of 51% with thromboplastin as an activator. The prothrombin antigen was 102%. This discordance in the functional and immunologic prothrombin levels was evidence for dysprothrombinemia. Western blotting showed that thrombin was formed at a normal rate in diluted plasma consistent with a mutation within the thrombin portion of prothrombin. DNA was isolated from leukocytes and the thrombin exons were For exon 13, eight clones were sequenced with four clones showing a point mutation in the codon for Arg((517), which would result in substitution by Gin. Arg(517) is part of the Arg-Gly Asp(RGD) sequence in thrombin and contributes to an ion cluster with aspartic acid residues 552 and 554. Mutation at this residue most probably distorts the structure of the Naf binding site in thrombin. This is the first report indicating the critical role of Arg(517) in the normal physiological interaction of thrombin with fibrinogen. This dysprothrombin is designated Prothrombin Greenville. (C) 1998 by The American Society of Hematology.
引用
收藏
页码:2026 / 2031
页数:6
相关论文
共 29 条
[1]   THE REFINED 1.9 A CRYSTAL-STRUCTURE OF HUMAN ALPHA-THROMBIN - INTERACTION WITH D-PHE-PRO-ARG CHLOROMETHYLKETONE AND SIGNIFICANCE OF THE TYR-PRO-PRO-TRP INSERTION SEGMENT [J].
BODE, W ;
MAYR, I ;
BAUMANN, U ;
HUBER, R ;
STONE, SR ;
HOFSTEENGE, J .
EMBO JOURNAL, 1989, 8 (11) :3467-3475
[2]  
BODE W, 1992, PROTEIN SCI, V1, P426
[3]   PARADOXIC EFFECT OF MULTIPLE MILD COAGULATION-FACTOR DEFICIENCIES ON THE PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME [J].
BURNS, ER ;
GOLDBERG, SN ;
WENZ, B .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1993, 100 (02) :94-98
[4]   AN ALLOSTERIC SWITCH CONTROLS THE PROCOAGULANT AND ANTICOAGULANT ACTIVITIES OF THROMBIN [J].
DANG, QD ;
VINDIGNI, A ;
DICERA, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (13) :5977-5981
[5]   Rational engineering of activity and specificity in a serine protease [J].
Dang, QD ;
Guinto, ER ;
DiCera, E .
NATURE BIOTECHNOLOGY, 1997, 15 (02) :146-149
[6]   NUCLEOTIDE-SEQUENCE OF THE GENE FOR HUMAN-PROTHROMBIN [J].
DEGEN, SJF ;
DAVIE, EW .
BIOCHEMISTRY, 1987, 26 (19) :6165-6177
[7]   CHARACTERIZATION OF THE COMPLEMENTARY DEOXYRIBONUCLEIC-ACID AND GENE CODING FOR HUMAN-PROTHROMBIN [J].
DEGEN, SJF ;
MACGILLIVRAY, RTA ;
DAVIE, EW .
BIOCHEMISTRY, 1983, 22 (09) :2087-2097
[8]  
DEGEN SJF, 1995, THROMB HAEMOSTASIS, V73, P203
[9]   SPECIFIC ASSAY OF PROTHROMBIN USING TAIPAN SNAKE VENOM [J].
DENSON, KWE ;
BORRETT, R ;
BIGGS, R .
BRITISH JOURNAL OF HAEMATOLOGY, 1971, 21 (02) :219-&
[10]   THE NA+ BINDING-SITE OF THROMBIN [J].
DICERA, E ;
GUINTO, ER ;
VINDIGNI, A ;
DANG, QD ;
AYALA, YM ;
WUYI, M ;
TULINSKY, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (38) :22089-22092